44 results
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
, skill sets, and leadership potential.
In January 2022, for the 2022 financial year, the Company’s Compensation Committee engaged Mercer (Canada … as lead director. The lead director is the representative of the independent directors to the Board. He provides leadership to ensure that the Board’s
6-K
EX-99.2
BLU
Bellus Health Inc
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
of responsibility, skill sets, and leadership potential.
In January 2022, for the 2022 financial year, the Company’s Compensation Committee engaged … is the representative of the independent directors to the Board. He provides leadership to ensure that the Board’s agenda will enable it to successfully carry
6-K
EX-99.1
BLU
Bellus Health Inc
29 Mar 23
Current report (foreign)
5:26pm
agencies could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed
SUPPL
BLU
Bellus Health Inc
14 Nov 22
Supplemental materials (foreign)
5:25pm
leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those … of, the FDA, the SEC and other government agencies could hinder their ability to hire and retain key leadership and other personnel, prevent new products
6-K
EX-99.1
BLU
Bellus Health Inc
16 Sep 22
Investor Presentation NASDAQ/TSX - BLU September 16 th , 2022
4:40pm
pro forma cash position *
Strong Leadership and Advisory Group Management Board of Directors Clinical Advisory Board Dr. Surinder Birring, MB ChB
F-10
3ltl3htupl
26 Aug 22
Registration of securities (Canada)
4:48pm
SUPPL
e1i52viz6fitkgkz3v2h
15 Jul 22
Supplemental materials (foreign)
7:01am
SUPPL
kga6tk9val1565uhbq3h
13 Jul 22
Supplemental materials (foreign)
5:01pm
6-K
EX-99.2
e7sgi
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
6-K
EX-99.1
zt6 76bg6
5 Apr 22
Current report (foreign)
4:07pm
40-F
EX-99.3
bt38ecgmjc7
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.1
n05l28p5r yyyscu14
23 Feb 22
Annual report (Canada)
5:20pm
6-K
EX-99.2
s0ctnhwwskx3
10 May 21
Condensed Consolidated Interim Financial Statements of
4:48pm
6-K
EX-99.2
nbb8bgly0gelfmnm6
9 Apr 21
Notice of Annual Meeting of Shareholders
12:00am
6-K
EX-99.1
ekqlcz 5wx2vs4km
8 Apr 21
Bellus HEALTH 2020 ANNUAL REPORT
10:16am
6-K
EX-99.1
bkbki6j mblyxzul
24 Mar 21
BELLUS Health Appoints William Mezzanotte, MD, MPH to its Board of Directors
7:00am
40-F
EX-99.3
2m5pp4vi
25 Feb 21
Annual report (Canada)
4:58pm
40-F
EX-99.1
2mnxolomt9c9j
25 Feb 21
Annual report (Canada)
4:58pm
6-K
EX-99.1
d727b5ce1c
7 Dec 20
Bellus Health Inc. 6-K
7:01am
SUPPL
pj0y9sh3f7u
20 Oct 20
Supplemental materials (foreign)
12:00am